Summary
An Australian tech entrepreneur, Paul Conyngham, developed a personalized cancer vaccine for his dog using artificial intelligence tools. The vaccine was made with help from the RNA Institute at the University of New South Wales and reduced the dog's cancer by 75%.
Key Facts
- Paul Conyngham is a tech entrepreneur with no medical background.
- He used AI tools like ChatGPT and AlphaFold to design a dog cancer vaccine.
- The RNA Institute at UNSW manufactured the vaccine.
- The process from sequence design to vaccine delivery took less than two months.
- The vaccine reduced the dog's cancer by about 75%.
- Conyngham and his team are investigating why some cancer did not respond to the vaccine.
- AI tools helped quickly personalize the vaccine to the specific needs of the dog's cancer.
